Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who are scheduled for or have already had a procedure to open blocked heart arteries (called a PCI, or percutaneous coronary intervention)
- People from whom a blood sample can be collected at the start of the trial
- People who have given their informed consent to participate
Who may not be able to join:
- People who are pregnant or breastfeeding
- People with serious liver or kidney problems
- People with an active autoimmune disease (a condition where the immune system attacks the body's own tissues)
- People whose important medical information or records are incomplete or missing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fang Wang, China-Japan Friendship Hospital
Phone: +86 13683173633
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite endpoint of NTL progression-related myocardial infarction or revascularization
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.